Sign in
4

Changes in Ownership

Taysha Gene Therapies, Inc. Filed Acc 0001709418-26-000002

Director acquired 21,335 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Stalfort John A III · Director

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2026-06-01 Grant or award : show line 1 in the form +21,335 1,176,559 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-06-01 Grant or award : show line 2 in the form Stock Option (right to buy) +42,671 42,671 D
Loading xslF345X06/form4-06022026_040616.xml…